Kelly Scientific is delighted to announce the rebranding of our business to Kelly Scientific and the launch of www.kellysci.com. We are committed to publishing high-impact cutting edge market analysis of our key niche areas in the healthcare industry.
Managing Director, Deirdre Kelly said ‘Our dedication to vertical growing industries has helped us become the pinnacle of market research today: We have significant expertise in Personalized & Precision Medicine, Companion Diagnostics, Targeted Therapeutics, Immuno-oncology and Drug Delivery markets, and our commitment to clients is second to none. Going forward, Kelly Scientific will continue to lead the market research space, as indicated by our Fortune 500 and big pharma clients.’
Kelly Scientific also provides market analysis for the Medical Aesthetic sector, as well as Biosimilar, Biomarker and Stem Cell industries. For more information email email@example.com